Elastic forecasts FY2027 revenue between $1.998 billion and $2.01 billion, and raised its non‑GAAP EPS outlook to $3.29–$3.37.
02
INITIAL SCENARIO
AI's Initial Call
Entry Rationale
The current price of $83.74 is near the resistance level of $88.21, limiting upside potential, but since it has not yet broken through the resistance, a buying opportunity is considered. Downside risk could arise near the support level of $62.93.
Target/Stop Scenario
If the stock price reaches the resistance level of $88.21, take profit; if the stock price falls to the support level of $62.93, cut loss. This is based on the resistance and support levels presented by REPORTING.
Take-profit reference$88.21
Stop-loss reference$62.93
03
TECHNICAL BASELINE
Market Data at Analysis Time
RSI64.5
Vs. Average Volume0.73×
Recent Change-5.0%
MA20$77.88MA60$66.24MA200$63.79
RSI(14) 64.5 – not overbought, but upward momentum is being maintained; moving‑average alignment is bullish – suggesting the uptrend may continue; trading volume is 0.73× the 20‑day average – low volume poses a risk that the trend could weaken; the 7‑day price change is –5.0% – recent prices have been declining.
AI LEARNING NOTE
Reviewing Prediction vs. Actual Result
Compared to the forecasted return of 15.0%, the actual return was 18.4%, exceeding the target. We correctly identified that the upward momentum was driven by the FY27 revenue and EPS upgrade outlook and an increased proportion of option buying, and buying near the resistance level proved to be a good entry. However, given that the upside potential was larger than expected, it would have been appropriate to set the target price even higher.
What to Watch in the Next Analysis
In the next trade, to offset low volume when buying near resistance, we will add volume confirmation, and when setting the target price we will allow a slight margin by considering the recent sharp rise. Additionally, we will continuously monitor the proportion of derivatives buying, such as options flow, to capture upward momentum early.
Investment Reference NoticeThis report is a record of past AI analysis being verified — it does not solicit buying or selling any specific stock. All investment decisions and responsibility rest with the user.